The Greening of Pharmaceutical Engineering; Volume 1: Practice, Analysis, and Methodology (Advanced Materials Series) by M.R. Islam, J.S. Islam, G.M. Zatzman, M.A.H. Mughal, and M. Safiur Rahman - 2015

Scrivener/Wiley, 2015. Hardbound. New Book. Hardbound. Islam, a consultant working in Canada on environment and energy-related issues, et al. offer this book, part of a four-volume set on the greening of pharmaceutical engineering. This first volume argues that low-income families are the most vulnerable and worst victims of the pharmaceutical industry, while pharmaceutical profits are increasing and rising health care costs contribute to inequality. It focuses on deconstructing theories of the root causes of disorders, and asserting the inadequacy of “new science” for conducting scientific investigation, showing how medicines don't cure diseases and how some make symptoms worse. It discusses the current state of Big Pharma and problems resulting from new science; the trend in the transformation of the natural into artificial, as exemplified in honey-sugar-saccharin-aspartame degradation; colony collapse disorder, which cannot be explained through new science; and the science behind the disinformation about the energy crisis, cancer, and autism spectrum disorder as examples of the deficiency of new science. It deconstructs the theories of Newton and Einstein as the basis of new science and posits how the nature-science approach can overcome problems of Newtonian-based methods of new science. (2015 Ringgold, Inc., Portland, OR)